View in EDS

Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
Authors: de Moraes FCA; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil., de Souza Wagner PH; Department of Medicine, Federal University of Santa Catarina, Florianópolis, Brazil., Hirata RDC; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil., Burbano RMR; Human Cytogenetics Laboratory, Biological Science Institute, Federal University of Pará, Belém, Brazil., Hirata MH; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2026 Jul; Vol. 26 (7), pp. 917-927. Date of Electronic Publication: 2026 Jan 21.
Publication Type: Journal Article; Systematic Review; Meta-Analysis; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41543026
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+Moraes+FCA%22">de Moraes FCA</searchLink>; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Souza+Wagner+PH%22">de Souza Wagner PH</searchLink>; Department of Medicine, Federal University of Santa Catarina, Florianópolis, Brazil.<br /><searchLink fieldCode="AU" term="%22Hirata+RDC%22">Hirata RDC</searchLink>; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Burbano+RMR%22">Burbano RMR</searchLink>; Human Cytogenetics Laboratory, Biological Science Institute, Federal University of Pará, Belém, Brazil.<br /><searchLink fieldCode="AU" term="%22Hirata+MH%22">Hirata MH</searchLink>; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101123358%22">Expert review of anticancer therapy</searchLink> [Expert Rev Anticancer Ther] 2026 Jul; Vol. 26 (7), pp. 917-927. <i>Date of Electronic Publication: </i>2026 Jan 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review; Meta-Analysis; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101123358 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8328 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214737140%22">14737140 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Anticancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41543026
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14737140.2026.2617952
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 917
    Titles:
      – TitleFull: Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de Moraes FCA
      – PersonEntity:
          Name:
            NameFull: de Souza Wagner PH
      – PersonEntity:
          Name:
            NameFull: Hirata RDC
      – PersonEntity:
          Name:
            NameFull: Burbano RMR
      – PersonEntity:
          Name:
            NameFull: Hirata MH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8328
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Expert review of anticancer therapy
              Type: main
ResultId 1